Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Bharat Biotech gets $15 mn upfront from Ocugen for rights to commercialise Covaxin in Canada

expresspharmaJune 09, 2021

Tag: Ocugen , Covaxin , Canada

PharmaSources Customer Service